The rise and fall of genomic methylation in cancer

Assam El-Osta1

  • 1The Alfred Medical Research and Education Precinct (AMREP), Epigenetics in Human Health and Disease Laboratory, Baker Medical Research Institute, Prahran, Victoria, Australia. assam.el-osta@baker.edu.au

Leukemia
|November 25, 2003
PubMed

Insights

Genomic hypomethylation, a loss of DNA methylation, is increasingly linked to cancer development and chromosomal instability. This review revisits this critical finding and its implications for understanding carcinogenesis.

Area of Science:

  • Epigenetics and Cancer Biology
  • Molecular Oncology

Background:

  • Genomic methylation changes are crucial in cancer.
  • Traditionally, DNA hypermethylation and tumor suppressor gene (TSG) silencing were the focus.
  • Recent evidence highlights the significance of genomic hypomethylation in carcinogenesis.

Purpose of the Study:

  • To review recent findings on genomic hypomethylation in cancer.
  • To discuss the link between DNA hypomethylation and chromosomal instability.
  • To re-examine the role of DNA methylation in carcinogenesis.

Main Methods:

  • Literature review of recent reports on genomic methylation and cancer.
  • Analysis of evidence linking hypomethylation to chromosomal instability.
  • Re-evaluation of historical studies on DNA methylation and carcinogenesis.

Main Results:

  • Compelling evidence supports the relevance of genomic hypomethylation in cancer.
  • Loss of DNA methylation is strongly associated with chromosomal instability.
  • These findings provide robust evidence for hypomethylation's role in cancer development.

Conclusions:

  • Genomic hypomethylation is a significant factor in cancer development.
  • The antithetical association between DNA methylation and carcinogenesis warrants re-examination.
  • Understanding hypomethylation is crucial for cancer research and therapy.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...